{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:28:00Z","timestamp":1786120080709,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"DOI":"10.1097\/qai.0b013e31822a9f8d","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T09:23:21Z","timestamp":1310721801000},"page":"e68-e74","source":"Crossref","is-referenced-by-count":16,"title":["Cost and Cost-Effectiveness of Switching From d4T or AZT to a TDF-Based First-Line Regimen in a Resource-Limited Setting in Rural Lesotho"],"prefix":"10.1097","volume":"58","author":[{"given":"Guillaume","family":"Jouquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Bygrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kranzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hilderbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Goemaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Vlahakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Trivino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipontso","family":"Makakole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-21-20210131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/COH.0b013e3283339b41","article-title":"Improving first-line antiretroviral therapy in resource-limited settings.","volume":"5","author":"Ford","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R4-21-20210131","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/596482","article-title":"Better adherence with once-daily antiretroviral regimens: a meta-analysis.","volume":"48","author":"Parienti","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-21-20210131","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1086\/649884","article-title":"Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.","volume":"50","author":"Bender","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R7-21-20210131","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/QAI.0b013e31817ae5ef","article-title":"Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa.","volume":"48","author":"Rosen","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-21-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1758-2652-12-23","article-title":"Antiretroviral treatment outcomes from a nurse-driven, community-supported HIVAIDS treatment programme in rural Lesotho: observational cohort assessment at two years.","volume":"12","author":"Cohen","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"R11-21-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R12-21-20210131","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2010.03.001","article-title":"The frequency and reasons for antiretroviral switching with specific antiretroviral associations: the SWITCH study.","volume":"86","author":"Davidson","year":"2010","journal-title":"Antiviral Res"},{"key":"R13-21-20210131","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/QAI.0b013e3182097505","article-title":"Implementing a tenofovir-based first-line regimen in rural Lesotho: clinical outcomes and toxicities after two years.","volume":"56","author":"Bygrave","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-21-20210131","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/QAD.0b013e328338e47a","article-title":"Advantages of low-cost generic tenofovir instead of D4T for first-line antiretroviral therapy in Burma: a 2-year experience.","volume":"24","author":"Moore","year":"2010","journal-title":"Aids"},{"key":"R16-21-20210131","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.clinthera.2008.02.009","article-title":"Cost-effectiveness analysis of emtricitabinetenofovir versus lamivudinezidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients.","volume":"30","author":"Sanchez-de la Rosa","year":"2008","journal-title":"Clin Ther"},{"key":"R18-21-20210131","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/135965350701200508","article-title":"International Epidemiological Databases to Evaluate Aids in Southern Africa Collaboration. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.","volume":"12","author":"Boulle","year":"2007","journal-title":"Antivir Ther"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201111010-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:07:30Z","timestamp":1786046850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201111010-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31822a9f8d","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}